MIL OSI Translation. Canadian French to English –
Source: Government of Canada – in French 1
Statement
September 26, 2024 | Ottawa, Ontario | Public Health Agency of Canada
Today we are pleased to announce the publication from the first year progress report of the Pan-Canadian Action Plan (PAP) on Antimicrobial Resistance. This report provides an overview of the activities underway and the milestones we have achieved with our federal, provincial and territorial partners during the first year of the Pan-Canadian Action Plan.
Antimicrobials, which include antibiotics, antifungals, antivirals, and antiparasitics, are essential medicines for preventing and treating infections in humans, animals, plants, and crops. Antimicrobial resistance occurs when microbes evolve and the medicines used to fight infections become less effective. As antimicrobial resistance increases, the ability to successfully treat infections is threatened, which can have serious consequences for the health of people, animals, and plants.
The report focuses on strengthening capacity to monitor antimicrobial resistance and use in Canada by developing the LNM National Laboratory Surveillance System for Antimicrobial Resistance for human and animal health, by publishing the reserve list of antimicrobial drugs Canadian guide to prescribers on which antimicrobial drugs to use sparingly to preserve their effectiveness, in investing in developing and sharing national guidelines for point-of-care antimicrobial prescribing to reduce unnecessary or inappropriate use of antimicrobials in human health, and in developing the Pilot project to increase the supply of antimicrobials in Canada, which will be launched later this year to improve access to antimicrobials for people in Canada.
Progress is also being made to support disease prevention and control in animals by facilitating access to alternatives to antimicrobials, such as vaccines, modernizing the Livestock Feed Regulations to support the use of innovative products in commercial livestock feed and to help reduce the need for antimicrobials, and by advancing research and innovation in antimicrobial resistance nationally and internationally, through theGenomics Research and Development Initiative on antimicrobial resistance,Assessment of antimicrobial resistance (AMR) and antimicrobial use (AMU) in food animals of the Canadian Academy of Health Sciences, and current involvement in theJoint Programming Initiative on Antimicrobial Resistance.
Antimicrobial resistance is a global crisis with far-reaching consequences. We are pleased to participate in this year’s United Nations High-Level Week at the General Assembly to reaffirm Canada’s commitment to combating antimicrobial resistance, share information on our progress, and engage with international health leaders and experts on key global health challenges.
Through our collective efforts, we can ensure that the antimicrobials we rely on every day remain effective and are available to people and animals when they need them – today and for generations to come.
To learn more about RAM: Canada.ca/antibiotics
Dr. Theresa TamChief Public Health Officer
Dr. Mary Jane IrelandChief Veterinarian
Contact persons
Media RelationsPublic Health Agency of Canada613-957-2983 media@hc-sc.gc.ca
Media RelationsCanadian Food Inspection Agency613-773-6600cfia.media.acia@inspection.gc.ca
EDITOR’S NOTE: This article is a translation. Apologies should the grammar and/or sentence structure not be perfect.